Premium
SR-17018
Analytical Samples
Available in >98% pure crystalline powder and unadultered 50mg research capsules. Formulated strictly for in vitro comparative analysis and G-Proten ligand research.
Advanced Research-Grade Compound
Superior Relief 17 provides high-purity reference material designed for analytical and in-vitro research. It supports the study of modern opioid receptor interactions and emerging harm reduction strategies.
The Evolution of Harm Reduction Research
The landscape of opioid use has shifted dramatically in recent years, moving from traditional botanicals like Kratom and pharmaceutical sources toward high-potency synthetic agonists including 7oh and MGM-15.
Compounds such as nitazenes (zenes) and cychlorphine present new challenges due to their extreme potency—often exceeding fentanyl—and rapid development of physiological tolerance.
As these substances become more prevalent, traditional transition methods are often ineffective or may lead to severe precipitated withdrawal. This creates an urgent need for research into alternative pathways, particularly those focused on biased signaling and tolerance reversal.
Addressing the Crisis Through Science
Our mission is to provide high-purity reference materials to support the study of these mechanisms.
By examining how SR-17018 interacts with receptors affected by high-potency synthetics, researchers are uncovering new insights into safer transition pathways and harm reduction strategies.
Providing access to these compounds for analytical and observational research is a critical step toward addressing the current crisis and advancing future solutions.
From the labs
Access detailed data, technical specifications, and research insights on SR-17018.